Anzeige
Mehr »
Freitag, 03.10.2025 - Börsentäglich über 12.000 News
Golden Cross macht sich bereit: 1.350 Goldabbaustellen, 55 Ladder-Ziele und ein historischer Volltreffer
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PBJC | ISIN: US03837C1062 | Ticker-Symbol: BOV
Tradegate
02.10.25 | 17:00
1,800 Euro
+1,12 % +0,020
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
APYX MEDICAL CORPORATION Chart 1 Jahr
5-Tage-Chart
APYX MEDICAL CORPORATION 5-Tage-Chart
RealtimeGeldBriefZeit
1,9301,96020:06
0,0000,00020:00

Aktuelle News zur APYX MEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
21.08.Apyx Medical stock rating reiterated as Market Perform by Citizens JMP1
APYX MEDICAL Aktie jetzt für 0€ handeln
08.08.Apyx Medical outlines $50M-$52M 2025 revenue targets as AYON presales surpass expectations and China launch advances2
07.08.Apyx Medical appoints two sales executives to support global expansion1
07.08.Apyx Medical Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)90CLEARWATER, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) ("Apyx Medical"; the "Company") today announced that on August 4, 2025, Apyx granted a nonstatuatory stock...
► Artikel lesen
28.07.Apyx Medical startet mit Renuvion in China durch Vertriebspartnerschaft1
28.07.Apyx Medical Corporation Announces Launch of Renuvion in China254Strong clinical interest and early procedures completed Entered into distribution agreement with GlamMoon, a division of BeauCare Clinics Investment Co., Ltd. post-initial market clearance CLEARWATER...
► Artikel lesen
24.07.Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2025 Financial Results on August 7, 20251
13.05.Apyx Medical Announces FDA Clearance For AYON Body Contouring System5
13.05.Apyx Medical gets FDA nod for AYON Body Contouring System2
13.05.Apyx Medical Corporation Receives FDA Clearance for the AYON Body Contouring System270The AYON Body Contouring System is the first FDA cleared all-in-one platform for the aesthetic surgical suite Plan to initiate the commercial launch of the AYON Body Contouring System to key opinion...
► Artikel lesen
08.05.Apyx Medical Corp - 10-Q, Quarterly Report-
08.05.Apyx Medical Corp - 8-K, Current Report-
29.04.Apyx Medical Corp - 8-K, Current Report1
29.04.Apyx Medical Corporation Announces Two Peer-Reviewed Publications on the Use of Renuvion in Abdominal Body Contouring Procedures2
24.04.Apyx Medical Corporation to Release First Quarter of Fiscal Year 2025 Financial Results on May 8, 20252
13.03.Apyx Medical Corporation Reports Fourth Quarter and Full Year 2024 Financial Results295The number of single-use handpiece units shipped in Q4 2024 exceeded expectations, increasing 5% overall and 20% in the U.S. compared to the same period last yearSubmitted a 510(k) premarket notification...
► Artikel lesen
06.01.Apyx Medical Corporation Submits 510(k) Premarket Notification to the U.S. Food and Drug Administration for the AYON Body Contouring System282CLEARWATER, Fla., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Apyx® Medical Corporation (NASDAQ:APYX) ("Apyx Medical"; the "Company"), the manufacturer of a proprietary helium plasma and radiofrequency technology...
► Artikel lesen
08.11.24Apyx Medical Corporation Reports Third Quarter 2024 Financial Results; Updates Full Year 2024 Financial Outlook and Introduces Full Year 2025 Financial Outlook185Strengthened balance sheet with a common stock registered direct offering with gross proceeds of approximately $7.0 million; and amended revenue covenants for the Company's credit agreement with PerceptiveAnnounces...
► Artikel lesen
18 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1